Pharming Group announces presentations at American College of Allergy, Asthma & Immunology Annual Scientific Meeting in November 2023
Pharming Group announces poster presentations by the Company or its collaborators regarding Ruconest at the American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting in November 2023.
Two poster presentations relating to Ruconest will be presented at ACAAI:
- Managing primary immunodeficiency immunoglobulin replacement therapy-related adverse events: Prophylaxis with recombinant human C1 esterase inhibitor; Poster #M234: Presented Friday 10 November 2023 at 15:00 Pacific Time (PT), Anaheim Convention Center Exhibit Hall
- On-demand treatment for hereditary angioedema attacks: Role of individualized management strategy; Poster #M150: Presented 12 November 2023 at 12:15 PT, Anaheim Convention Center Exhibit Hall
In addition to displaying in the exhibit hall at the noted times, ePosters will be accessible online and on demand to registered attendees on Thursday, November 9, 2023, beginning at 08:00 PT on ACAAI’s website.
(Source: Pharming)
